Cargando…

Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics

Widespread application of omic technologies is evolving our understanding of population health and holds promise in providing precise guidance for selection of therapeutic interventions based on patient biology. The opportunity to use hundreds of analytes for diagnostic assessment of human health co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tolstikov, Vladimir, Moser, A. James, Sarangarajan, Rangaprasad, Narain, Niven R., Kiebish, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345110/ https://www.ncbi.nlm.nih.gov/pubmed/32485899 http://dx.doi.org/10.3390/metabo10060224

Ejemplares similares

Integrated Metabolomics Assessment of Human Dried Blood Spots and Urine Strips
por: Drolet, Jeremy, et al.
Publicado: (2017)

Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
por: Chi, Jen‐Tsan, et al.
Publicado: (2020)

Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies
por: Searfoss, Richard, et al.
Publicado: (2022)

Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers
por: Sarangarajan, Rangaprasad, et al.
Publicado: (2020)

Dynamic and temporal assessment of human dried blood spot MS/MS(ALL) shotgun lipidomics analysis
por: Gao, Fei, et al.
Publicado: (2017)

OMRT-13. Delivery of Ubidecarenone (BPM 31510) to mitochondria effectuates metabolic reprogramming and redox activated apoptosis in Glioblastoma
por: Sarangarajan, Rangaprasad, et al.
Publicado: (2021)

Divergence in the metabolome between natural aging and Alzheimer’s disease
por: Hunsberger, Holly C., et al.
Publicado: (2020)

Author Correction: Divergence in the metabolome between natural aging and Alzheimer’s disease
por: Hunsberger, Holly C., et al.
Publicado: (2020)

Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis
por: Mishra, Prachi, et al.
Publicado: (2019)

Monoacylglycerol Analysis Using MS/MS(ALL) Quadruple Time of Flight Mass Spectrometry
por: Gao, Fei, et al.
Publicado: (2016)

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer
por: Kiebish, Michael A., et al.
Publicado: (2020)

High levels of ubidecarenone (oxidized CoQ(10)) delivered using a drug-lipid conjugate nanodispersion (BPM31510) differentially affect redox status and growth in malignant glioma versus non-tumor cells
por: Sun, Jiaxin, et al.
Publicado: (2020)

Perturbation of the yeast mitochondrial lipidome and associated membrane proteins following heterologous expression of Artemia-ANT
por: Chen, Emily, et al.
Publicado: (2018)

Chronic stress and antidepressant treatment alter purine metabolism and beta oxidation within mouse brain and serum
por: Hamilton, Peter J., et al.
Publicado: (2020)

A Comprehensive Workflow of Mass Spectrometry-Based Untargeted Metabolomics in Cancer Metabolic Biomarker Discovery Using Human Plasma and Urine
por: Zou, Wei, et al.
Publicado: (2013)

Comparative analysis of differentially abundant proteins quantified by LC–MS/MS between flash frozen and laser microdissected OCT-embedded breast tumor samples
por: Sturtz, Lori A., et al.
Publicado: (2020)

Ubc1 turnover contributes to the spindle assembly checkpoint in Saccharomyces cerevisiae
por: Arsenault, Heather E, et al.
Publicado: (2021)

Metabolomics: Bridging the Gap between Pharmaceutical Development and Population Health
por: Tolstikov, Vladimir
Publicado: (2016)

Dysregulation of the calcium handling protein, CCDC47, is associated with diabetic cardiomyopathy
por: Thapa, Khampaseuth, et al.
Publicado: (2018)

Hsp90β knockdown in DIO mice reverses insulin resistance and improves glucose tolerance
por: Jing, Enxuan, et al.
Publicado: (2018)

Hypothesis-Agnostic Network-Based Analysis of Real-World Data Suggests Ondansetron is Associated with Lower COVID-19 Any Cause Mortality
por: Miller, Gregory M., et al.
Publicado: (2022)

Metabolomics and Biomarkers for Drug Discovery
por: Yeung, Pollen K.
Publicado: (2018)

Dynamics of the gut microbiome, IgA response, and plasma metabolome in the development of pediatric celiac disease
por: Girdhar, Khyati, et al.
Publicado: (2023)

Functional metabolomics: from biomarker discovery to metabolome reprogramming
por: Peng, Bo, et al.
Publicado: (2015)

Intrinsic Properties of Brown and White Adipocytes Have Differential Effects on Macrophage Inflammatory Responses
por: Dowal, Louisa, et al.
Publicado: (2017)

Older adults with sarcopenia have distinct skeletal muscle phosphodiester, phosphocreatine, and phospholipid profiles
por: Hinkley, James Matthew, et al.
Publicado: (2020)

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia
por: Kiebish, Michael A., et al.
Publicado: (2021)

Proteomic and metabolomic approaches to biomarker discovery
por: Issaq, Haleem J, et al.
Publicado: (2019)

Metabolomics for Biomarker Discovery in Gastroenterological Cancer
por: Nishiumi, Shin, et al.
Publicado: (2014)

Metabolomics for Biomarker Discovery: Moving to the Clinic
por: Zhang, Aihua, et al.
Publicado: (2015)

Biomarker discovery for tuberculosis using metabolomics
por: Yu, Yi, et al.
Publicado: (2023)

Metabolomics-Based Discovery of Diagnostic Biomarkers for Onchocerciasis
por: Denery, Judith R., et al.
Publicado: (2010)

Proteomics in Biomarker Discovery for Tuberculosis: Current Status and Future Perspectives
por: Guo, Jiubiao, et al.
Publicado: (2022)

Skeletal Muscle Energetics and Mitochondrial Function Are Impaired Following 10 Days of Bed Rest in Older Adults
por: Standley, Robert A, et al.
Publicado: (2020)

Statistical methods and resources for biomarker discovery using metabolomics
por: Anwardeen, Najeha R., et al.
Publicado: (2023)

Identification of Filamin-A and -B as potential biomarkers for prostate cancer
por: Narain, Niven R, et al.
Publicado: (2016)

The metabolome identity: basis for discovery of biomarkers in neurodegeneration
por: Bourgognon, Julie-Myrtille, et al.
Publicado: (2019)

Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers
por: Gómez-Cebrián, Nuria, et al.
Publicado: (2019)

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020)

The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
por: Wu, Xinghong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_31epjfgubi5uvm7n1for6lqdrv